EMA — authorised 16 April 2008
- Marketing authorisation holder: Bristol-Myers Squibb Pharma EEIG
- Status: approved
🇪🇺 Thalomid in European Union
EMA authorised Thalomid on 16 April 2008
Marketing authorisation
Thalomid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Thalomid approved in European Union?
Yes. EMA authorised it on 16 April 2008.
Who is the marketing authorisation holder for Thalomid in European Union?
Bristol-Myers Squibb Pharma EEIG holds the EU marketing authorisation.